Efficacy of cardiac myosin inhibitors mavacamten and aficamten in hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomised controlled trials

Background Unlike other suggested therapies, myosin inhibitors have been shown to change the course of hypertrophic cardiomyopathy by altering the contractile mechanics of cardiomyocytes. This meta-analysis sought to determine the efficacy of mavacamten and aficamten in hypertrophic cardiomyopathy.M...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayesha Aman, Arfa Akram, Bisma Akram, Momina Maham, Masooma Zainab Bokhari, Aleena Akram, Sania Akram, Furqan Yaqub
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/12/1/e003215.full
Tags: Add Tag
No Tags, Be the first to tag this record!